Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.53 |
| ▸ | LMNA | P02545 | 2/20 | 0.50 |
| ▸ | CNR2 | P34972 | 1/20 | 0.49 |
| ▸ | PAM | P19021 | 2/20 | 0.48 |
| ▸ | SPHK2 | Q9NRA0 | 1/20 | 0.48 |
| ▸ | SPHK1 | Q9NYA1 | 1/20 | 0.48 |
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CES2 | O00748 | 3/20 | 0.46 |
| ▸ | CES1 | P23141 | 3/20 | 0.46 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.46 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.46 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | TP53 | P04637 | 1/20 | 0.46 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.46 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28133365 | 1.00 | DGKA (0.53) | DGKALMNACNR2PAMSPHK2 | |
| SCHEMBL1180260 | 1.00 | DGKA (0.53) | DGKALMNACNR2PAMSPHK2 | |
| SCHEMBL1179755 | 1.00 | DGKA (0.53) | DGKALMNACNR2PAMSPHK2 | |
| SCHEMBL9273172 | 1.00 | DGKA (0.53) | DGKALMNACNR2PAMSPHK2 | |
| SCHEMBL27838257 | 0.98 | DGKA (0.52) | DGKALMNACNR2PAMSPHK2 | |
| SCHEMBL11254862 | 0.98 | DGKA (0.50) | DGKALMNACNR2PAMSPHK2 | |
| SCHEMBL27668283 | 0.94 | DGKA (0.48) | DGKALMNACNR2PAMSPHK2 | |
| SCHEMBL2172442 | 0.92 | CES1 (0.42) | DGKALMNACNR2PAMSPHK2 | |
| SCHEMBL9276219 | 0.90 | CNR2 (0.64) | LMNACNR2MAPTMEN1FAAH | |
| SCHEMBL27500866 | 0.89 | TSHR (0.40) | DGKALMNACNR2PAMMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20140179936-A1 | EPOXIDATION OF GLYCEROL AND DERIVATIVES THEREFROM | AEL MINING SERVICES LIMITED (ZA) | 2014-06-26 | — | — | US | disclosed |
| US-8558038-B2 | Epoxidation of glycerol and derivatives therefrom | AEL MINING SERVICES LIMITED (ZA) | 2013-10-15 | — | — | US | disclosed |
| US-20130090497-A1 | EPOXIDATION OF GLYCEROL AND DERIVATIVES THEREFROM | AEL MINING SERVICES LIMITED (ZA) | 2013-04-11 | — | — | US | disclosed |
| WO-2012003519-A1 | EPOXIDATION OF GLYCEROL AND DERIVATIVES THEREFROM | AEL MINING SERVICES LIMITED (ZA) | 2012-01-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140179936-A1 | EPOXIDATION OF GLYCEROL AND DERIVATIVES THEREFROM | GK, UGCG, GYPA | DGKA 53/4885LMNA 2360/4885CNR2 714/4885 |
| US-20130090497-A1 | EPOXIDATION OF GLYCEROL AND DERIVATIVES THEREFROM | GK, UGCG, GYPA | DGKA 53/4885LMNA 2360/4885CNR2 714/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.